Rituxmab Versus IL-6 in Treating ILD

Clinical trial NCT05963048 · COMPLETED

Trial details

NCT number: NCT05963048
Sponsor: Assiut University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Interstitial Lung Disease Scleroderma

Start date: 2021-12-01
Primary completion: 2022-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.